{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:07:01Z","timestamp":1791864421058,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,21]]},"DOI":"10.7759\/cureus.36481","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T17:54:19Z","timestamp":1679421259000},"source":"Crossref","is-referenced-by-count":12,"title":["Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review"],"prefix":"10.7759","author":[{"given":"Madiha","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Skopit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2012.04.004","article-title":"Linear IgA disease: clinical presentation, diagnosis, and pathogenesis","volume":"32","author":"Venning VA","year":"2012","unstructured":"Venning VA. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Immunol Allergy Clin North Am. 2012, 32:245-53, vi. 10.1016\/j.iac.2012.04.004","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03897.x","article-title":"Linear IgA bullous dermatosis responsive to a gluten-free diet","volume":"96","author":"Egan CA","year":"2001","unstructured":"Egan CA, Smith EP, Taylor TB, Meyer LJ, Samowitz WS, Zone JJ. Linear IgA bullous dermatosis responsive to a gluten-free diet. Am J Gastroenterol. 2001, 96:1927-9. 10.1111\/j.1572-0241.2001.03897.x","journal-title":"Am J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.12.030","article-title":"Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: two case reports","volume":"21","author":"Herlin LK","year":"2022","unstructured":"Herlin LK, Deleuran M, Pallesen K, Bregnh\u00f8j A. Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: two case reports. JAAD Case Rep. 2022, 21:119-22. 10.1016\/j.jdcr.2021.12.030","journal-title":"JAAD Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.66601","article-title":"Linear IgA bullous dermatosis of childhood: response to thalidomide","volume":"76","author":"Madnani NA","year":"2010","unstructured":"Madnani NA, Khan KJ. Linear IgA bullous dermatosis of childhood: response to thalidomide. Indian J Dermatol Venereol Leprol. 2010, 76:427-9. 10.4103\/0378-6323.66601","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080818","article-title":"Updates in the diagnosis and management of linear IgA disease: a systematic review","volume":"57","author":"Shin L","year":"2021","unstructured":"Shin L, Gardner JT 2nd, Dao H Jr. Updates in the diagnosis and management of linear IgA disease: a systematic review. Medicina (Kaunas). 2021, 57:818. 10.3390\/medicina57080818","journal-title":"Medicina (Kaunas)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2011.06.014","article-title":"Management of linear IgA disease","volume":"29","author":"Ng SY","year":"2011","unstructured":"Ng SY, Venning VV. Management of linear IgA disease. Dermatol Clin. 2011, 29:629-30. 10.1016\/j.det.2011.06.014","journal-title":"Dermatol Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15989","article-title":"Neonatal and self-healing linear immunoglobulin A dermatosis","volume":"34","author":"Giraud L","year":"2020","unstructured":"Giraud L, Welfringer-Morin A, Boccara O, et al.. Neonatal and self-healing linear immunoglobulin A dermatosis. J Eur Acad Dermatol Venereol. 2020, 34:e86-7. 10.1111\/jdv.15989","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.80406","article-title":"Linear IgA bullous dermatosis in tunisian children: 31 cases","volume":"56","author":"Monia K","year":"2011","unstructured":"Monia K, Aida K, Amel K, Ines Z, Becima F, Ridha KM. Linear IgA bullous dermatosis in tunisian children: 31 cases. Indian J Dermatol. 2011, 56:153-9. 10.4103\/0019-5154.80406","journal-title":"Indian J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00438.x","article-title":"Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid","volume":"24","author":"Ho JC","year":"2007","unstructured":"Ho JC, Ng PL, Tan SH, Giam YC. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid. Pediatr Dermatol. 2007, 24:E40-3. 10.1111\/j.1525-1470.2007.00438.x","journal-title":"Pediatr Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12220","article-title":"Linear IgA bullous dermatosis of childhood: good response to antibiotic treatment","volume":"39","author":"de las Heras MN","year":"2014","unstructured":"de las Heras MN. Linear IgA bullous dermatosis of childhood: good response to antibiotic treatment. Clin Exp Dermatol. 2014, 39:395-7. 10.1111\/ced.12220","journal-title":"Clin Exp Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70056-8","article-title":"Chronic bullous disease of childhood: successful treatment with dicloxacillin","volume":"39","author":"Siegfried E","year":"1998","unstructured":"Siegfried E, Sirawan S. Chronic bullous disease of childhood: successful treatment with dicloxacillin. J Am Acad Dermatol. 1998, 39:797-800. 10.1016\/S0190-9622(98)70056-8","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1995.tb00131.x","article-title":"Treatment of chronic bullous dermatosis of childhood with oral dicloxacillin","volume":"12","author":"Skinner RB Jr","year":"1995","unstructured":"Skinner RB Jr, Rotondo CK, Schneider MA, Raby L, Rosenberg EW. Treatment of chronic bullous dermatosis of childhood with oral dicloxacillin. Pediatr Dermatol. 1995, 12:65-6. 10.1111\/j.1525-1470.1995.tb00131.x","journal-title":"Pediatr Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1102","article-title":"Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin","volume":"54","author":"Alajlan A","year":"2006","unstructured":"Alajlan A, Al-Khawajah M, Al-Sheikh O, Al-Saif F, Al-Rasheed S, Al-Hoqail I, Hamadah IR. Treatment of linear IgA bullous dermatosis of childhood with flucloxacillin. J Am Acad Dermatol. 2006, 54:652-6. 10.1016\/j.jaad.2005.11.1102","journal-title":"J Am Acad Dermatol"},{"key":"ref14","article-title":"Linear IgA bullous dermatosis of childhood successfully treated with flucloxacillin","volume":"18","author":"Braga-Tavares H","year":"2008","unstructured":"Braga-Tavares H, Carro E, Ros\u00e1rio C, Taveira M. Linear IgA bullous dermatosis of childhood successfully treated with flucloxacillin. Eur J Pediat Dermatol. 2008, 18:137-9.","journal-title":"Eur J Pediat Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00817.x","article-title":"Childhood linear IgA bullous dermatosis in Tunisia","volume":"26","author":"Kenani N","year":"2009","unstructured":"Kenani N, Mebazaa A, Denguezli M, Ghariani N, Sriha B, Belajouza C, Nouira R. Childhood linear IgA bullous dermatosis in Tunisia. Pediatr Dermatol. 2009, 26:28-33. 10.1111\/j.1525-1470.2008.00817.x","journal-title":"Pediatr Dermatol"},{"key":"ref16","article-title":"IgA linear bullous dermatosis in children. A series of 12 Tunisian patients","volume":"121","author":"Denguezli M","year":"1994","unstructured":"Denguezli M, Ben Nejma B, Nouira R, et al.. IgA linear bullous dermatosis in children. A series of 12 Tunisian patients. Ann Dermatol Venereol. 1994, 121:888-92.","journal-title":"Ann Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.29328\/journal.adr.1001005","article-title":"Linear IgA bullous dermatosis in a child successfully responding to oral antibiotics","volume":"2","author":"Senhaji G","year":"2018","unstructured":"Senhaji G, Bay H, Dassouli R, et al.. Linear IgA bullous dermatosis in a child successfully responding to oral antibiotics. Ann Dermatol Res. 2018, 2:008-011. 10.29328\/journal.adr.1001005","journal-title":"Ann Dermatol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(99)70504-9","article-title":"Linear iga bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy","volume":"40","author":"Khan I","year":"1999","unstructured":"Khan I, Bhol K, Ahmed A. Linear iga bullous dermatosis in a patient with chronic renal failure: response to intravenous immunoglobulin therapy. J Am Acad Dermatol. 1999, 40:485-8. 10.1016\/s0190-9622(99)70504-9","journal-title":"J Am Acad Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00245-1","article-title":"Linear iga bullous disease limited to the eye: a diagnostic dilemma response to intravenous immunoglobulin therapy","volume":"107","author":"Letko E","year":"2000","unstructured":"Letko E, Bhol K, Foster S, Ahmed R. Linear iga bullous disease limited to the eye: a diagnostic dilemma response to intravenous immunoglobulin therapy. Ophthalmology. 2000, 107:1524-8. 10.1016\/S0161-6420(00)00245-1","journal-title":"Ophthalmology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.12.314","article-title":"A case of refractory linear IgA disease responsive to high-dose intravenous immunoglobulin therapy","volume":"50","author":"Jang H","year":"2018","unstructured":"Jang H, Cai F, Kaufman A, Broadfoot A, Fernando S. A case of refractory linear IgA disease responsive to high-dose intravenous immunoglobulin therapy. Pathology. 2018, 50:111. 10.1016\/j.pathol.2017.12.314","journal-title":"Pathology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.06.029","article-title":"High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases","volume":"56","author":"Segura S","year":"2007","unstructured":"Segura S, Iranzo P, Mart\u00ednez-de Pablo I, Mascar\u00f3 JM Jr, Alsina M, Herrero J, Herrero C. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. J Am Acad Dermatol. 2007, 56:960-7. 10.1016\/j.jaad.2006.06.029","journal-title":"J Am Acad Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03395.x","article-title":"High-dose intravenous immune globulin is also effective in linear IgA disease","volume":"142","author":"Kroiss MM","year":"2000","unstructured":"Kroiss MM, Vogt T, Landthaler M, Stolz W. High-dose intravenous immune globulin is also effective in linear IgA disease. Br J Dermatol. 2000, 142:582. 10.1046\/j.1365-2133.2000.03395.x","journal-title":"Br J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.01.059","article-title":"Unusual clinical manifestation of linear IgA dermatosis: a report of two cases","volume":"51","author":"Cauza K","year":"2004","unstructured":"Cauza K, Hinterhuber G, Sterniczky B, et al.. Unusual clinical manifestation of linear IgA dermatosis: a report of two cases. J Am Acad Dermatol. 2004, 51:S112-7. 10.1016\/j.jaad.2004.01.059","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3662","article-title":"Intravenous immunoglobulins in a series of 32 rare and recalcitrant immune dermatoses","volume":"100","author":"Scarpone R","year":"2020","unstructured":"Scarpone R, Meier K, Ghoreschi K, Worm M. Intravenous immunoglobulins in a series of 32 rare and recalcitrant immune dermatoses. Acta Derm Venereol. 2020, 100:adv00298. 10.2340\/00015555-3662","journal-title":"Acta Derm Venereol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.1999.99015.x","article-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","volume":"16","author":"Ang P","year":"1999","unstructured":"Ang P, Tay YK. Treatment of linear IgA bullous dermatosis of childhood with colchicine. Pediatr Dermatol. 1999, 16:50-2. 10.1046\/j.1525-1470.1999.99015.x","journal-title":"Pediatr Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01321.x","article-title":"Localized linear IgA disease responding to colchicine","volume":"41","author":"Benbenisty KM","year":"2002","unstructured":"Benbenisty KM, Bowman PH, Davis LS. Localized linear IgA disease responding to colchicine. Int J Dermatol. 2002, 41:56-8. 10.1046\/j.1365-4362.2002.01321.x","journal-title":"Int J Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0001-7310(06)73463-9","article-title":"Linear IgA bullous dermatosis of adults treated with colchicine","volume":"97","author":"Hern\u00e1ndez-Mach\u00edn B","year":"2006","unstructured":"Hern\u00e1ndez-Mach\u00edn B, Pe\u00f1ate Y, B\u00e1ez B, Borrego L. Linear IgA bullous dermatosis of adults treated with colchicine. Actas Dermosifiliogr. 2006, 97:549-50. 10.1016\/s0001-7310(06)73463-9","journal-title":"Actas Dermosifiliogr"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1984.01650430150027","article-title":"Linear IgA bullous dermatosis. Successful treatment with colchicine","volume":"120","author":"Aram H","year":"1984","unstructured":"Aram H. Linear IgA bullous dermatosis. Successful treatment with colchicine. Arch Dermatol. 1984, 120:960-1.","journal-title":"Arch Dermatol"},{"key":"ref29","article-title":"Case reports of linear IgA bullous dermatosis of childhood","volume":"28","author":"Ang P","year":"1999","unstructured":"Ang P, Goh BK, Giam YC. Case reports of linear IgA bullous dermatosis of childhood. Ann Acad Med Singap. 1999, 28:849-54.","journal-title":"Ann Acad Med Singap"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7318305","article-title":"A rare case of vancomycin-induced linear immunoglobulin A bullous dermatosis","volume":"2017","author":"Jha P","year":"2017","unstructured":"Jha P, Swanson K, Stromich J, Michalski BM, Olasz E. A rare case of vancomycin-induced linear immunoglobulin A bullous dermatosis. Case Rep Dermatol Med. 2017, 2017:7318305. 10.1155\/2017\/7318305","journal-title":"Case Rep Dermatol Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omz004","article-title":"Bullous dermatosis suspected in an 8-month-old child in Guinea-Bissau","volume":"2019","author":"Valle Del Barrio B","year":"2019","unstructured":"Valle Del Barrio B, Luraschi D, Micheletti R, Hiffler L, Arias AP. Bullous dermatosis suspected in an 8-month-old child in Guinea-Bissau. Oxf Med Case Reports. 2019, 2019:omz004. 10.1093\/omcr\/omz004","journal-title":"Oxf Med Case Reports"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2018.11.004","article-title":"Linear IgA bullous dermatosis treated with rituximab","volume":"5","author":"Pinard C","year":"2019","unstructured":"Pinard C, Hebert V, Lecuyer M, Sacre L, Joly P. Linear IgA bullous dermatosis treated with rituximab. JAAD Case Rep. 2019, 5:124-6. 10.1016\/j.jdcr.2018.11.004","journal-title":"JAAD Case Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.12.029","article-title":"Immunologic overlap in a case of linear IgG\/IgA bullous dermatosis responsive to rituximab","volume":"9","author":"Nedosekin D","year":"2021","unstructured":"Nedosekin D, Wilson KD, Campbell K, Shalin S, Wong HK. Immunologic overlap in a case of linear IgG\/IgA bullous dermatosis responsive to rituximab. JAAD Case Rep. 2021, 9:57-60. 10.1016\/j.jdcr.2020.12.029","journal-title":"JAAD Case Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1089-2","article-title":"Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients","volume":"14","author":"Genovese G","year":"2019","unstructured":"Genovese G, Venegoni L, Fanoni D, Muratori S, Berti E, Marzano AV. Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients. Orphanet J Rare Dis. 2019, 14:115. 10.1186\/s13023-019-1089-2","journal-title":"Orphanet J Rare Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12911","article-title":"A case of recalcitrant linear IgA bullous dermatosis: successfully treated with rituximab","volume":"32","author":"Kaya \u0130slamo\u011flu ZG","year":"2019","unstructured":"Kaya \u0130slamo\u011flu ZG, Aky\u00fcrek FT. A case of recalcitrant linear IgA bullous dermatosis: successfully treated with rituximab. Dermatol Ther. 2019, 32:e12911. 10.1111\/dth.12911","journal-title":"Dermatol Ther"},{"key":"ref36","article-title":"Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders","volume":"151","author":"Lozinski A","year":"2012","unstructured":"Lozinski A, Baum S, Sagi L, Volkov A, Trau H, Barzilai A. Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders. Harefuah. 2012, 151:562-5, 606.","journal-title":"Harefuah"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915205","article-title":"Rituximab therapy for mucous membrane pemphigoid: a retrospective monocentric study with long-term follow-up in 109 patients","volume":"13","author":"Bohelay G","year":"2022","unstructured":"Bohelay G, Alexandre M, Le Roux-Villet C, et al.. Rituximab therapy for mucous membrane pemphigoid: a retrospective monocentric study with long-term follow-up in 109 patients. Front Immunol. 2022, 13:915205. 10.3389\/fimmu.2022.915205","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_223_21","article-title":"Successful treatment of refractory chronic bullous disease of childhood with rituximab","volume":"13","author":"Mitra D","year":"2022","unstructured":"Mitra D, Bhatnagar A, Singh GK, Sandhu S. Successful treatment of refractory chronic bullous disease of childhood with rituximab. Indian Dermatol Online J. 2022, 13:248-51. 10.4103\/idoj.idoj_223_21","journal-title":"Indian Dermatol Online J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04131.x","article-title":"Mixed immunobullous disease of childhood: a good response to antimicrobials","volume":"144","author":"Powell J","year":"2001","unstructured":"Powell J, Kirtschig G, Allen J, Dean D, Wojnarowska F. Mixed immunobullous disease of childhood: a good response to antimicrobials. Br J Dermatol. 2001, 144:769-74. 10.1046\/j.1365-2133.2001.04131.x","journal-title":"Br J Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01133.x","article-title":"Linear IgA disease: successful treatment with erythromycin","volume":"27","author":"Cooper SM","year":"2002","unstructured":"Cooper SM, Powell J, Wojnarowska F. Linear IgA disease: successful treatment with erythromycin. Clin Exp Dermatol. 2002, 27:677-9. 10.1046\/j.1365-2230.2002.01133.x","journal-title":"Clin Exp Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00741.x","article-title":"Is erythromycin an effective treatment for chronic bullous disease of childhood? A national survey of members of the British Society for Paediatric Dermatology","volume":"25","author":"Farrant P","year":"2008","unstructured":"Farrant P, Darley C, Carmichael A. Is erythromycin an effective treatment for chronic bullous disease of childhood? A national survey of members of the British Society for Paediatric Dermatology. Pediatr Dermatol. 2008, 25:479-82. 10.1111\/j.1525-1470.2008.00741.x","journal-title":"Pediatr Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/000155502320323351","article-title":"Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil","volume":"82","author":"Gl\u00e4ser R","year":"2002","unstructured":"Gl\u00e4ser R, Sticherlin M. Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil. Acta Derm Venereol. 2002, 82:308-9. 10.1080\/000155502320323351","journal-title":"Acta Derm Venereol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.9.1121","article-title":"Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil","volume":"139","author":"Farley-Li J","year":"2003","unstructured":"Farley-Li J, Mancini AJ. Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil. Arch Dermatol. 2003, 139:1121-4. 10.1001\/archderm.139.9.1121","journal-title":"Arch Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2005.01741.x","article-title":"Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent","volume":"30","author":"Talhari C","year":"2005","unstructured":"Talhari C, Mahnke N, Ruzicka T, Megahed M. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent. Clin Exp Dermatol. 2005, 30:297-8. 10.1111\/j.1365-2230.2005.01741.x","journal-title":"Clin Exp Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2006.09.019","article-title":"Successful treatment of oral linear IgA disease using mycophenolate","volume":"103","author":"Lewis MA","year":"2007","unstructured":"Lewis MA, Yaqoob NA, Emanuel C, Potts AJ. Successful treatment of oral linear IgA disease using mycophenolate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 103:483-6. 10.1016\/j.tripleo.2006.09.019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1590\/s0365-05962011000400018","article-title":"Linear IgA\/IgG bullous dermatosis: successful treatment with dapsone and mycophenolate mofetil","volume":"86","author":"Passos L","year":"2011","unstructured":"Passos L, Rabelo RF, Matsuo C, Santos M, Talhari S, Talhari C. Linear IgA\/IgG bullous dermatosis: successful treatment with dapsone and mycophenolate mofetil. An Bras Dermatol. 2011, 86:747-50. 10.1590\/s0365-05962011000400018","journal-title":"An Bras Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1080\/09546630801958246","article-title":"Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium","volume":"19","author":"Marzano AV","year":"2008","unstructured":"Marzano AV, Ramoni S, Spinelli D, Alessi E, Berti E. Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium. J Dermatolog Treat. 2008, 19:364-7. 10.1080\/09546630801958246","journal-title":"J Dermatolog Treat"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(08)80585-3","article-title":"Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide","volume":"26","author":"Peoples D","year":"1992","unstructured":"Peoples D, Fivenson D. Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide. J Am Acad Dermatol. 1992, 26:498-9. 10.1016\/s0190-9622(08)80585-3","journal-title":"J Am Acad Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)80651-2","article-title":"Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases","volume":"28","author":"Chaffins M","year":"1993","unstructured":"Chaffins M, Collison D, Fivenson D. Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol. 1993, 28:998-1000. 10.1016\/S0190-9622(08)80651-2","journal-title":"J Am Acad Dermatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02996.x","article-title":"Sublamina densa-type linear IgA bullous dermatosis successfully treated with oral tetracycline and niacianamide","volume":"141","author":"Yomada M","year":"1999","unstructured":"Yomada M, Komai A, Hashimato T. Sublamina densa-type linear IgA bullous dermatosis successfully treated with oral tetracycline and niacianamide. Br J Dermatol. 1999, 141:608-9. 10.1046\/j.1365-2133.1999.02996.x","journal-title":"Br J Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12524","article-title":"A case of linear IgA dermatosis successfully treated with tetracycline and niacinamide","volume":"55","author":"Shan XF","year":"2016","unstructured":"Shan XF, Zhang FR, Tian HQ, Wang N, Zhou SJ, Wang GJ. A case of linear IgA dermatosis successfully treated with tetracycline and niacinamide. Int J Dermatol. 2016, 55:e216-7. 10.1111\/ijd.12524","journal-title":"Int J Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12892","article-title":"Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide","volume":"41","author":"Cui YX","year":"2016","unstructured":"Cui YX, Yang BQ, Zhou GZ, Zhang FR. Childhood linear IgA bullous dermatosis successfully treated with oral nicotinamide. Clin Exp Dermatol. 2016, 41:816-8. 10.1111\/ced.12892","journal-title":"Clin Exp Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20131949","article-title":"Linear IgA dermatosis associated with ulcerative colitis: complete and sustained remission after total colectomy","volume":"88","author":"Vargas TJ","year":"2013","unstructured":"Vargas TJ, Fialho M, Santos LT, Rodrigues PA, Vargas AL, Sousa MA. Linear IgA dermatosis associated with ulcerative colitis: complete and sustained remission after total colectomy. An Bras Dermatol. 2013, 88:600-3. 10.1590\/abd1806-4841.20131949","journal-title":"An Bras Dermatol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2009.0794","article-title":"Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy","volume":"19","author":"Caldarola G","year":"2009","unstructured":"Caldarola G, Annese V, Bossa F, Pellicano R. Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy. Eur J Dermatol. 2009, 19:651. 10.1684\/ejd.2009.0794","journal-title":"Eur J Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03928.x","article-title":"Remission of linear IgA disease associated with ulcerative colitis following panproclocolectomy","volume":"143","author":"Walker SL","year":"2000","unstructured":"Walker SL, Banerjee P, Harland CC, Black MM. Remission of linear IgA disease associated with ulcerative colitis following panproclocolectomy. Br J Dermatol. 2000, 143:1341-2. 10.1046\/j.1365-2133.2000.03928.x","journal-title":"Br J Dermatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1993.tb00371.x","article-title":"Chronic bullous disease of childhood and ulcerative colitis","volume":"10","author":"Handley J","year":"1993","unstructured":"Handley J, Shields M, Dodge J, Walsh M, Bingham A. Chronic bullous disease of childhood and ulcerative colitis. Pediatr Dermatol. 1993, 10:256-8. 10.1111\/j.1525-1470.1993.tb00371.x","journal-title":"Pediatr Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.2.214","article-title":"Ulcerative colitis and immunobullous disease cured by colectomy","volume":"135","author":"Egan CA","year":"1999","unstructured":"Egan CA, Meadows KP, Zone JJ. Ulcerative colitis and immunobullous disease cured by colectomy. Arch Dermatol. 1999, 135:214-5. 10.1001\/archderm.135.2.214","journal-title":"Arch Dermatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.5070\/D3247040919","article-title":"Linear IgA bullous dermatosis associated with ulcerative proctitis: treatment challenge","volume":"24","author":"Yetto T","year":"2018","unstructured":"Yetto T, Burns C. Linear IgA bullous dermatosis associated with ulcerative proctitis: treatment challenge. Dermatol Online J. 2018, 24:13030\/qt46421332. 10.5070\/D3247040919","journal-title":"Dermatol Online J"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3109\/09546639209092758","article-title":"Methotrexate and cyclosporin are of value in the treatment of adult linear IgA disease","volume":"3","author":"Burrows N","year":"1992","unstructured":"Burrows N, Jones R. Methotrexate and cyclosporin are of value in the treatment of adult linear IgA disease. J Dermatolog Treat. 1992, 3:31-3. 10.3109\/09546639209092758","journal-title":"J Dermatolog Treat"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_906_20","article-title":"Coexistence of psoriasis and linear IgA disease: an uncommon presentation","volume":"88","author":"Neema S","year":"2021","unstructured":"Neema S, Bhatt S, Kashif AW, Radhakrishnan S. Coexistence of psoriasis and linear IgA disease: an uncommon presentation. Indian J Dermatol Venereol Leprol. 2021, 88:101-3. 10.25259\/IJDVL_906_20","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03625.x","article-title":"Linear IgA disease: successful treatment with cyclosporin","volume":"143","author":"Young HS","year":"2000","unstructured":"Young HS, Coulson IH. Linear IgA disease: successful treatment with cyclosporin. Br J Dermatol. 2000, 143:204-5. 10.1046\/j.1365-2133.2000.03625.x","journal-title":"Br J Dermatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.07.070","article-title":"Chronic bullous dermatosis of childhood and the string of pearls sign","volume":"202","author":"Tate C","year":"2018","unstructured":"Tate C, Christian W, Newell L. Chronic bullous dermatosis of childhood and the string of pearls sign. J Pediatr. 2018, 202:325.e1. 10.1016\/j.jpeds.2018.07.070","journal-title":"J Pediatr"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(10)63209-X","article-title":"Certolizumab treatment of linear IgA dermatosis in a pregnant crohn's colitis catient: a case study and review of the literature","volume":"138","author":"Steinberg S","year":"2010","unstructured":"Steinberg S, Ullman T. Certolizumab treatment of linear IgA dermatosis in a pregnant crohn's colitis catient: a case study and review of the literature. Gastroenterology. 2010, 138:698. 10.1016\/S0016-5085(10)63209-X","journal-title":"Gastroenterology"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15400","article-title":"Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment","volume":"178","author":"Prieto-Barrios M","year":"2018","unstructured":"Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, Burillo-Martinez S, Zarco-Olivo C, Rodriguez-Peralto JL, Ortiz-Romero PL. Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment. Br J Dermatol. 2018, 178:786-9. 10.1111\/bjd.15400","journal-title":"Br J Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1159\/000355354","article-title":"Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab","volume":"227","author":"Yamada S","year":"2013","unstructured":"Yamada S, Makino T, Jinnin M, Sakai K, Fukushima S, Inoue Y, Ihn H. Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab. Dermatology. 2013, 227:295-8. 10.1159\/000355354","journal-title":"Dermatology"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2016.09.002","article-title":"Linear IgA dermatosis after infliximab infusion for ulcerative colitis","volume":"2","author":"Bryant KD","year":"2016","unstructured":"Bryant KD, DeNunzio MJ, Ford MJ. Linear IgA dermatosis after infliximab infusion for ulcerative colitis. JAAD Case Rep. 2016, 2:448-50. 10.1016\/j.jdcr.2016.09.002","journal-title":"JAAD Case Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.08.019","article-title":"Linear IgA bullous dermatosis successfully treated with omalizumab: a case report","volume":"5","author":"Maalouf NS","year":"2019","unstructured":"Maalouf NS, Hanna D. Linear IgA bullous dermatosis successfully treated with omalizumab: a case report. JAAD Case Rep. 2019, 5:966-9. 10.1016\/j.jdcr.2019.08.019","journal-title":"JAAD Case Rep"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5368","article-title":"Linear IgA\/IgG bullous dermatosis successfully treated with omalizumab: a case report","volume":"10","author":"Haulrig MB","year":"2022","unstructured":"Haulrig MB, Nielsen SL, Elberling J, Skov L. Linear IgA\/IgG bullous dermatosis successfully treated with omalizumab: a case report. Clin Case Rep. 2022, 10:e05368. 10.1002\/ccr3.5368","journal-title":"Clin Case Rep"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_55_20","article-title":"A case of linear IgA bullous dermatosis successfully treated with omalizumab","volume":"65","author":"Patel NH","year":"2020","unstructured":"Patel NH, Padhiyar JK, Patel TD, Trivedi NS, Chandibhamar VS, Raval R. A case of linear IgA bullous dermatosis successfully treated with omalizumab. Indian J Dermatol. 2020, 65:543-5. 10.4103\/ijd.IJD_55_20","journal-title":"Indian J Dermatol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.267","article-title":"Challenging treatment of linear IgA dermatosis in a patient with dapsone-induced hypersensitivity syndrome","volume":"76","author":"Cetkovska P","year":"2017","unstructured":"Cetkovska P, Komorousova M, Kojanova M, Lomicova I, Novak M, Stork J. Challenging treatment of linear IgA dermatosis in a patient with dapsone-induced hypersensitivity syndrome. J Am Acad Dermatol. 2017, 76:64. 10.1016\/j.jaad.2017.04.267","journal-title":"J Am Acad Dermatol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13210","article-title":"Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine","volume":"33","author":"Yang Z","year":"2020","unstructured":"Yang Z, Liu ZH, Sun CQ, Shen H. Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine. Dermatol Ther. 2020, 33:e13210. 10.1111\/dth.13210","journal-title":"Dermatol Ther"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2007.02509.x","article-title":"Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole","volume":"32","author":"Peterson JD","year":"2007","unstructured":"Peterson JD, Chan LS. Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole. Clin Exp Dermatol. 2007, 32:756-8. 10.1111\/j.1365-2230.2007.02509.x","journal-title":"Clin Exp Dermatol"},{"key":"ref73","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2230.1997.tb02627.x","article-title":"Linear IgA bullous dermatosis of childhood: treatment with dapsone and co-trimoxazole","volume":"22","author":"Pulimood S","year":"1997","unstructured":"Pulimood S, Ajithkumar K, Jacob M, George S, Chandi SM. Linear IgA bullous dermatosis of childhood: treatment with dapsone and co-trimoxazole. Clin Exp Dermatol. 1997, 22:90-1.","journal-title":"Clin Exp Dermatol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3315\/jdcr.2010.1053","article-title":"Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole","volume":"4","author":"Nantel-Battista M","year":"2010","unstructured":"Nantel-Battista M, Al Dhaybi R, Hatami A, Marcoux D, Desroches A, Kokta V. Childhood linear IgA bullous disease induced by trimethoprim-sulfamethoxazole. J Dermatol Case Rep. 2010, 4:33-5. 10.3315\/jdcr.2010.1053","journal-title":"J Dermatol Case Rep"},{"key":"ref75","doi-asserted-by":"crossref","DOI":"10.5070\/D3238036012","article-title":"Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"23","author":"Baltazard T","year":"2017","unstructured":"Baltazard T, Dhaille F, Duvert-Lehembre S, Lok C, Chaby G. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Dermatol Online J. 2017, 23:13030\/qt9gv0j00w.","journal-title":"Dermatol Online J"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02315.x","article-title":"Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis","volume":"22","author":"Dauendorffer JN","year":"2008","unstructured":"Dauendorffer JN, Mah\u00e9 E, Saiag P. Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis. J Eur Acad Dermatol Venereol. 2008, 22:364-5. 10.1111\/j.1468-3083.2007.02315.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.06.021","article-title":"Mucosal linear IgA disease with esophageal involvement responsive to ustekinumab","volume":"15","author":"Jimenez A","year":"2021","unstructured":"Jimenez A, Topham C, Varedi D, Leiferman KM, Hull C. Mucosal linear IgA disease with esophageal involvement responsive to ustekinumab. JAAD Case Rep. 2021, 15:4-6. 10.1016\/j.jdcr.2021.06.021","journal-title":"JAAD Case Rep"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.11.955","article-title":"Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab","volume":"67","author":"Becker JG","year":"2012","unstructured":"Becker JG, Mundi JP, Newlove T, Mones J, Shupack J. Development of linear IgA bullous dermatosis in a patient with psoriasis taking ustekinumab. J Am Acad Dermatol. 2012, 67:e150-1. 10.1016\/j.jaad.2011.11.955","journal-title":"J Am Acad Dermatol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1159\/000279318","article-title":"Linear IgA disease: successful application of immunoadsorption and review of the literature","volume":"220","author":"Kasperkiewicz M","year":"2010","unstructured":"Kasperkiewicz M, Meier M, Zillikens D, Schmidt E. Linear IgA disease: successful application of immunoadsorption and review of the literature. Dermatology. 2010, 220:259-63. 10.1159\/000279318","journal-title":"Dermatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131629-management-options-for-linear-immunoglobulin-a-iga-bullous-dermatosis-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:44Z","timestamp":1707508664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131629-management-options-for-linear-immunoglobulin-a-iga-bullous-dermatosis-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":79,"URL":"https:\/\/doi.org\/10.7759\/cureus.36481","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}